Chemours Co (CC): debt financing — Chemours extends $1.05B term loan to 2032 and secures €180M factoring facility

Chemours Co

Extended maturity of $1.05B Term Loan B-3 US$ to Oct 2032 from Aug 2028; margin Term SOFR+3.50%.
Entered €180M receivables factoring agreement with BNP Paribas; initial term to Oct 2026, auto-renewal.
Chemours subsidiaries sell up to €180M eligible receivables; parent guarantees obligations.
Actions improve liquidity and extend debt maturity profile.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Chemours Co amended term loan of $1,050,000,000 with JPMorgan Chase Bank, N.A., as administrative agent at adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50% maturing October 15, 2032.

Instrument: term loan
Principal: $1,050,000,000
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Rate: adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50%
Maturity: October 15, 2032
Event: amendment

Exact text from the filing

The Amendment extended the maturity date of the Company’s $1,050,000,000 senior secured U.S. dollar-denominated term loan facility (the “Term Loan B-3 US$ Facility”) from August 18, 2028 to October 15, 2032.

View on SEC.gov

304 debt financings filed in the last 30 days. Browse all debt financings →

Chemours Co filing history →

Source: SEC EDGAR

accession 0001193125-25-240643

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.